| Company/Division name | Boehringer Ingelheim |
| Parent company | Boehringer Ingelheim |
| Type of work | Manufacturing |
| If manufacturing, is the company an OEM? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2017 |
| Year reshoring implemented or to be implemented: | 2019 |
| Capital investment ($): | 80 |
| Country(ies) from which reshored: | Germany,United States |
| City reshored to: | St Joseph |
| State(s) reshored to: | MO |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | animal vaccines |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Higher productivity, Impact on domestic economy |
